Molecular Farming Breakthrough: Social media buzz erupted around Moolec Science's announcement of successfully expressing bovine myoglobin in pea seeds, a world-first achievement in molecular farming. The news propelled the stock up 65% in a single session, highlighting potential to transform food technology. Traders highlighted the innovation's promise amid surging interest in biotech alternatives.
Speculative Gains Amid Risks: Enthusiasm on social media focused on the stock's rapid climb to $11.44, fueled by accelerated FDA timelines and the GLA purity milestone. However, participants cautioned about the company's -177% profit margins and negative equity, labeling it a high-risk play. Discussions underscored the speculative nature despite the positive catalyst.
Shareholder Shift: Recent talk also noted Agriculture Investment Group becoming the controlling shareholder, adding to the narrative of strategic backing. This development intertwined with the breakthrough hype, drawing comparisons to top daily gainers. Sentiment reflected optimism tempered by volatility concerns.
Note: This discussion summary was generated from an AI condensation of post data.
Moolec Science Hedge Fund Activity
We have seen 1 institutional investors add shares of Moolec Science stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INSIGNEO ADVISORY SERVICES, LLC removed 24,359 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,201
- UBS GROUP AG removed 10,505 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2,674
- CITADEL ADVISORS LLC removed 2,415 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $614
- XTX TOPCO LTD added 1,819 shares (+inf%) to their portfolio in Q4 2025, for an estimated $463
- MORGAN STANLEY removed 82 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $20
- SBI SECURITIES CO., LTD. removed 27 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6
- JPMORGAN CHASE & CO added 0 shares (+nan%) to their portfolio in Q4 2025, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
